Published in Indian Journal of Medical Research, study classifies nearly 10% prescriptions as 'unacceptable', says such lapses can lead to adverse drug reactions & risk patient health.
Swiss drugmaker Roche Pharma says Ocrelizumab can help manage multiple sclerosis & impede disability progression. Doctors welcome launch but caution against potential side effects.
The two drugs – Leqembi and Donanemab – are the first to offer real hope of slowing the fatal disease for 6.5 million Americans living with the disease.
At least 70 children died from acute kidney injury in Gambia last year, cases the WHO linked to medicines made by Indian drugmaker Maiden Pharmaceuticals.
Revumenib found to be promising in 2 studies by US researchers published in 'Nature' Wednesday. Leukaemia accounted for nearly 4% of global cancer deaths in 2020.
While lecanemab saw less decline in cognition and function of patients, the drug is effective only at a very early stage -- closer to the onset of the disease.
Gurugram: In an action that will significantly impact the value of property transactions in Haryana, Chief Minister Nayab Singh Saini has approved revised collector rates,...
As Narendra Modi becomes India’s second-longest consecutively serving Prime Minister, we look at how he compares with Indira Gandhi across four key dimensions.
COMMENTS